By detecting cancer early, patients may have access to preventative measures and proactive treatment. QIAGEN Digital Insights is improving hereditary cancer risk detection.
Testing for hereditary cancers can detect specific, heritable, disease-related gene mutations that may increase the risk of certain cancers allowing an in-depth cancer risk assessment for each patient.
The critical goal is to detect cancer early and to maximize health outcomes for patients. Patient-tailored screening programs, preventive measures and proactive treatment are possible for patients of a high-risk group. Early diagnosis can mean a better overall prognosis through a choice of surgical and non-surgical treatment options.
The largest, manually curated resource for finding disease-causing mutations
Software for rapid NGS variant annotation, filtering and triage
Clinical decision support software for NGS variant interpretation and reporting
Learn more about QIAGEN’s QIAseq Custom Panels.